<!-- received="Wed Oct  6 06:19:44 1999 MST" -->
<!-- sent="Wed, 6 Oct 1999 08:18:51 EDT" -->
<!-- name="GBurch1@aol.com" -->
<!-- email="GBurch1@aol.com" -->
<!-- subject="Re: SOC: Activism and the "Anti-GM" Movement" -->
<!-- id="ad4b4234.252c982b@aol.com" -->
<!-- inreplyto="SOC: Activism and the "Anti-GM" Movement" -->
<!-- version=1.10, linesinbody=131 -->
<html><head><title>extropians: Re: SOC: Activism and the "Anti-GM" Movement</title>
<meta name=author content="GBurch1@aol.com">
<link rel=author rev=made href="mailto:GBurch1@aol.com" title ="GBurch1@aol.com">
</head><body>
<h1>Re: SOC: Activism and the "Anti-GM" Movement</h1>
<i>GBurch1@aol.com</i><br>
<i>Wed, 6 Oct 1999 08:18:51 EDT</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#346">[ date ]</a><a href="index.html#346">[ thread ]</a><a href="subject.html#346">[ subject ]</a><a href="author.html#346">[ author ]</a>
<!-- next="start" -->
<li><a href="0347.html">[ Next ]</a><a href="0345.html">[ Previous ]</a>
<b>In reply to:</b> <a href="0254.html">Chris Fedeli</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="0353.html">Robert J. Bradbury</a>
</ul>
<!-- body="start" -->

<p>
In a message dated 99-10-06 00:48:56 EDT, bradbury@www.aeiveos.com (Robert J. 
Bradbury) wrote:

<p>
<a href="0341.html#0346qlink1">&gt; &gt; Organized groups opposed to rational use of genetic technology have made </a><br>
<i>&gt; the </i><br>
<i>&gt;  &gt; complete banning of genetically modified food and the use of advanced </i><br>
<i>&gt; genetic </i><br>
<i>&gt;  &gt; technology in human medical applications a key policy objective.</i><br>
<i>&gt;  </i><br>
<a name="0353qlink1"><i>&gt;  Please cite references here for "use of advanced genetic technology in</i><br>
<i>&gt;  human medical applications"</i><br>

<p>
Only time for a very quick reply now (maybe more later today -- Robert, I 
think you consistently overestimate the rationality of "the mainstream" . . . 
</a>
<a name="0353qlink2">.).  For the nonce, I'll just repost something we saw on the list</a> just 
yesterday:

<p>
<a href="0254.html#0346qlink2">&gt;          -------------------------------------------</a><br>
<i>&gt;</i><br>
<i>&gt;                         Welcome to the</i><br>
<i>&gt;</i><br>
<i>&gt;                   Techno-Eugenics Email List</i><br>
<i>&gt;</i><br>
<i>&gt;                           Number 1</i><br>
<i>&gt;</i><br>
<i>&gt;                       September 10, 1999</i><br>
<i>&gt;</i><br>
<i>&gt;          -------------------------------------------</i><br>
<i>&gt;</i><br>
<i>&gt; WELCOME TO TEEL</i><br>
<i>&gt;</i><br>
<i>&gt; This is the first edition of the Techno-Eugenics Email List.</i><br>
<i>&gt; As far as we know, it's the only list focused on the politics</i><br>
<i>&gt; of the new human genetic and reproductive technologies.</i><br>

<p>
[they don't know much, do they]

<p>
<i>&gt;</i><br>
<a href="0254.html#0346qlink3">&gt; We support biotechnology in the public interest.  We oppose</a><br>
<i>&gt; policies and biotechnologies--including human germline</i><br>
<i>&gt; engineering and human cloning--that foster inequality,</i><br>
<i>&gt; discrimination, objectification, and the commodification</i><br>
<i>&gt; of human genes and tissues.</i><br>

<p>
[?]

<p>
<i>&gt;</i><br>
<a href="0254.html#0346qlink4">&gt; The pace of developments has picked up considerably in the</a><br>
<i>&gt; past several months.  And glimmers of opposition are starting</i><br>
<i>&gt; to emerge.  But most Americans--including most activists and</i><br>
<i>&gt; academics--have no idea that a small group of influential</i><br>
<i>&gt; scientists have launched a campaign to promote germline</i><br>
<i>&gt; engineering, human cloning, and a techno-eugenic future.</i><br>

<p>
[!]

<p>
<i>&gt;</i><br>
<a href="0254.html#0346qlink5">&gt; We've begun working to change that situation: to alert the</a><br>
<i>&gt; public about the new technologies and the techno-eugenic vision;</i><br>
<i>&gt; to educate environmental, social justice, women's health, public</i><br>
<i>&gt; health, and other groups; and to create organized opposition.</i><br>
<i>&gt;</i><br>
<i>&gt; TEEL will consist largely of announcements about relevant</i><br>
<i>&gt; events (especially in California), brief updates on important</i><br>
<i>&gt; developments, and pointers to useful information.</i><br>
<i>&gt;</i><br>
<i>&gt; For at least the next several months, TEEL will be irregular</i><br>
<i>&gt; (a couple times a month), informal, and non-automated.  We'd</i><br>
<i>&gt; welcome feedback, and suggestions about focus and format.</i><br>
<i>&gt; A web site will be coming soon.</i><br>
<i>&gt;</i><br>
<i>&gt; Marcy Darnovsky will moderate.  Send her submissions at the</i><br>
<i>&gt; email address below.</i><br>
<i>&gt;</i><br>
<i>&gt; This first edition is being sent to people with whom we've</i><br>
<i>&gt; been in contact about human cloning, germline engineering,</i><br>
<i>&gt; genetic enhancement, and related issues.</i><br>
<i>&gt;</i><br>
<i>&gt; Feel free to pass TEEL on to</i><br>
<i>&gt; others who may be interested in becoming involved, and</i><br>
<i>&gt; encourage them to subscribe.  No obligations!</i><br>
<i>&gt;</i><br>
<i>&gt; Marcy Darnovsky                  Rich Hayes</i><br>
<i>&gt; teel@adax.com                    rhayes@socrates.berkeley.edu</i><br>
<i>&gt;</i><br>
<i>&gt; ---------------------------------------------------------------</i><br>
<i>&gt;</i><br>
<i>&gt; POINTERS</i><br>
<i>&gt;</i><br>
<i>&gt; --  Briefing paper on "The Threat of the New Human Techno-</i><br>
<i>&gt; Eugenics," by Rich Hayes.  8 pages.  Available from</i><br>
<i>&gt; rhayes@socrates.berkeley.edu.</i><br>
<i>&gt;</i><br>
<i>&gt; --  GeneWatch, the newsletter of the Council for Responsible</i><br>
<i>&gt; Genetics, has just published an excellent special issue</i><br>
<i>&gt; (August 1999) on human cloning.  Subscription information:</i><br>
<i>&gt; CRG, 5 Upland Road, Suite 3, Cambridge, MA 02140.  Phone:</i><br>
<i>&gt; 617-868-0870.   Individual subscriptions (6 issues) are $24.</i><br>
<i>&gt;</i><br>
<i>&gt; --  Wild Duck Review special issue on biotechnology, with</i><br>
<i>&gt; detailed discussion of human genetic technologies.  For</i><br>
<i>&gt; information about copies, email Casey Walker, editor, at</i><br>
<i>&gt; casey@wildduckreview.com.</i><br>
<i>&gt;</i><br>
<i>&gt; -- For the best recent short statement in a prestigious</i><br>
<i>&gt; medical journal against human germline engineering, see</i><br>
<i>&gt; "Human Germline Gene Modification:  A Dissent," Paul</i><br>
<i>&gt; Billings, Ruth Hubbard, and Stuart Newman.  The Lancet</i><br>
<i>&gt; Vol 353 Number 9167, 29 May 1999.</i><br>
<i>&gt;</i><br>
<i>&gt; --  Notes on the first two meetings of the California Cloning</i><br>
<i>&gt; Committee, including testimony from Paul Billings of Council</i><br>
<i>&gt; for Responsible Genetics.  Available from Rich Hayes,</i><br>
<i>&gt; rhayes@socrates.berkeley.edu.</i><br>
<i>&gt;</i><br>
<i>&gt; --  ABC News "Nightline in Primetime" aired a special on human</i><br>
<i>&gt; cloning on August 19, 1999.  Anchor Ted Koppel and correspondent</i><br>
<i>&gt; Robert Krulwich joined featured guest Lee Silver in endorsing</i><br>
<i>&gt; human genetic enhancement.  A 5-page summary is available from</i><br>
<i>&gt; Marcy Darnovsky, teel@adax.com.  Video copies and transcripts are</i><br>
<i>&gt; available from ABC News (abcnews.com), which also has a web site</i><br>
<i>&gt; based on the special at <a href="http://abcnews.go.com/onair/popoff/bnw">http://abcnews.go.com/onair/popoff/bnw</a> .</i><br>
<i>&gt;</i><br>
<i>&gt; --  A list of recent books on the new human genetic technologies</i><br>
<i>&gt; is available from Marcy Darnovsky, teel@adax.com.</i><br>
<i>&gt;</i><br>
<i>&gt; --  Notes on the acquisition by Geron, a Menlo Park biotech</i><br>
<i>&gt; company, of Roslin Bio-Med and the nuclear transfer technology</i><br>
<i>&gt; used to create Dolly, the cloned sheep.  2 pages.  Available</i><br>
<i>&gt; from Marcy Darnovsky, teel@adax.com.</i><br>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="0347.html">[ Next ]</a><a href="0345.html">[ Previous ]</a>
<b>In reply to:</b> <a href="0254.html">Chris Fedeli</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="0353.html">Robert J. Bradbury</a>
</ul>
</body></html>
